Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy
Li Li(Qingdao University), Gerben A. Koning(Università Cattolica del Sacro Cuore), Dieter Haemmerich(Medical University of South Carolina), Martin Hossann(Max Planck Institute of Biochemistry), Timo L.M. ten Hagen(Erasmus MC), Alexander Eggermont(University Medical Center Utrecht), Regine Süss(University of Freiburg), Gerard C. van Rhoon(Erasmus MC Cancer Institute)
Cited by 206
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
TNF-α in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility
|The Oncologist|2006|711
Health Council of the Netherlands: No need to change from SAR to time-temperature relation in electromagnetic fields exposure limits
|International Journal of Hyperthermia|2011|606
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Classification of current anticancer immunotherapies
|Oncotarget|2014|469